Lane DP - Search Results

1

p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding.

Midgley CA, Lane DP. Midgley CA, et al. Among authors: lane dp. Oncogene. 1997 Sep 4;15(10):1179-89. doi: 10.1038/sj.onc.1201459. Oncogene. 1997. PMID: 9294611

2

An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53.

Vojtĕsek B, Bártek J, Midgley CA, Lane DP. Vojtĕsek B, et al. Among authors: lane dp. J Immunol Methods. 1992 Jul 6;151(1-2):237-44. doi: 10.1016/0022-1759(92)90122-a. J Immunol Methods. 1992. PMID: 1378473

3

Assessment of p53 protein expression in normal, benign, and malignant oral mucosa.

Ogden GR, Kiddie RA, Lunny DP, Lane DP. Ogden GR, et al. Among authors: lane dp. J Pathol. 1992 Apr;166(4):389-94. doi: 10.1002/path.1711660411. J Pathol. 1992. PMID: 1381431

4

Regulation of the specific DNA binding function of p53.

Hupp TR, Meek DW, Midgley CA, Lane DP. Hupp TR, et al. Among authors: lane dp. Cell. 1992 Nov 27;71(5):875-86. doi: 10.1016/0092-8674(92)90562-q. Cell. 1992. PMID: 1423635

5

Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli.

Midgley CA, Fisher CJ, Bártek J, Vojtĕsek B, Lane D, Barnes DM. Midgley CA, et al. J Cell Sci. 1992 Jan;101 ( Pt 1):183-9. doi: 10.1242/jcs.101.1.183. J Cell Sci. 1992. PMID: 1569122

6

Ras-induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation.

Lu X, Park SH, Thompson TC, Lane DP. Lu X, et al. Among authors: lane dp. Cell. 1992 Jul 10;70(1):153-61. doi: 10.1016/0092-8674(92)90541-j. Cell. 1992. PMID: 1623518

7

The conformational change of a murine temperature-sensitive p53 protein is independent of a change in phosphorylation status.

Picksley SM, Meek DW, Lane DP. Picksley SM, et al. Among authors: lane dp. Oncogene. 1992 Aug;7(8):1649-51. Oncogene. 1992. PMID: 1630825

8

p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia.

Bártková J, Bártek J, Lukás J, Vojtĕsek B, Stasková Z, Rejthar A, Kovarík J, Midgley CA, Lane DP. Bártková J, et al. Among authors: lane dp. Int J Cancer. 1991 Sep 9;49(2):196-202. doi: 10.1002/ijc.2910490209. Int J Cancer. 1991. PMID: 1652567

9

p53 immunostaining as a marker of malignant disease in diagnostic cytopathology.

Hall PA, Ray A, Lemoine NR, Midgley CA, Krausz T, Lane DP. Hall PA, et al. Among authors: lane dp. Lancet. 1991 Aug 24;338(8765):513. doi: 10.1016/0140-6736(91)90586-e. Lancet. 1991. PMID: 1678471 No abstract available.

10

Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer.

Horak E, Smith K, Bromley L, LeJeune S, Greenall M, Lane D, Harris AL. Horak E, et al. Oncogene. 1991 Dec;6(12):2277-84. Oncogene. 1991. PMID: 1685017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

500 results

Search Page

Filters